Kura Oncology (KURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,443 | 1,124 | 7 | 5 | 4 |
| Marketable Securities | 70,303 | N/A | N/A | N/A | N/A |
| Receivables | 430 | 30 | N/A | N/A | N/A |
| TOTAL | $86,869 | $1,196 | $9 | $8 | $7 |
| Non-Current Assets | |||||
| PPE Net | 71 | 27 | N/A | N/A | N/A |
| Other Non-Current Assets | 319 | 155 | 0 | 0 | 0 |
| TOTAL | $390 | $182 | $N/A | $N/A | $N/A |
| Total Assets | $87,259 | $1,378 | $9 | $8 | $7 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,055 | 980 | 0 | 2 | 3 |
| Accrued Expenses | N/A | N/A | 23 | 17 | 12 |
| TOTAL | $5,055 | $3,016 | $133 | $104 | $75 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 101 | 1,795 | 0 | 0 | 0 |
| TOTAL | $101 | $1,795 | $N/A | $N/A | $N/A |
| Total Liabilities | $5,156 | $4,811 | $133 | $104 | $75 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,371 | N/A | N/A | N/A | N/A |
| Common Shares | 2 | N/A | 1 | 1 | 1 |
| Retained earnings | -26,296 | -3,671 | -174 | -145 | -118 |
| Other shareholders' equity | -87 | 0 | 0 | 0 | 0 |
| TOTAL | $82,103 | $-3,433 | $-124 | $-95 | $-68 |
| Total Liabilities And Equity | $87,259 | $1,378 | $9 | $8 | $7 |